Signaling pathways
-
BA5684 AR-C118925XXSummary: AR-C118925XX is a selective receptor antagonist. -
BA5685 BPTUSummary: BPTU (BMS-646786) is a non-nucleotide receptor variant antagonist with antithrombotic activity. -
BA5686 VicagrelSummary: Vicagrel is an effective and safe antiplatelet agent with oral activity that acts by irreversibly inhibiting the P2Y12 receptor. -
BA5687 PITSummary: PIT (2,2'-Pyridylisatogentosylate) is a selective and non-competitive antagonist. -
BA5689 ElinogrelSummary: Elinogrel (PRT060128) is an effective. -
BA5690 MRS2395Summary: MRS2395 is a dipentanoyl derivative and is a potent receptor antagonist. -
BA5691 PA-8Summary: PA-8 is a potent, selective, orally active PACAPI-type receptor antagonist. -
BA5692 PA-9Summary: PA-9 is a pituitary adenylate cyclase-activating polypeptide (PACAP) type I receptor antagonist. -
BA5693 ForopafantSummary: Foropafant (SR27417) is a potent, competitive, selective, orally available platelet-activating factor receptor antagonist. -
BA5694 KadsurenoneSummary: Kadsurenone is a lignan with platelet-activating factor-specific antagonistic activity.

